NUS(NUS)
NUS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.43B | $1.53B |
| Low | $1.43B | $1.53B |
| High | $1.43B | $1.53B |
| EBITDA Avg | $128M | $138M |
| Low | $128M | $138M |
| High | $128M | $138M |
| EBIT Avg | $74M | $80M |
| Low | $74M | $80M |
| High | $74M | $80M |
| Net Income Avg | $50M | $66M |
| Low | $50M | $66M |
| High | $50M | $66M |
| EPS Avg | $1.00 | $1.32 |
| Low | $1.00 | $1.32 |
| High | $1.00 | $1.32 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $376M | $384M | $357M | $388M | $390M | $395M |
| Low | $376M | $384M | $357M | $388M | $390M | $395M |
| High | $376M | $384M | $357M | $388M | $390M | $395M |
| EBITDA Avg | $34M | $35M | $32M | $35M | $35M | $36M |
| Low | $34M | $35M | $32M | $35M | $35M | $36M |
| High | $34M | $35M | $32M | $35M | $35M | $36M |
| EBIT Avg | $20M | $20M | $19M | $20M | $20M | $21M |
| Low | $20M | $20M | $19M | $20M | $20M | $21M |
| High | $20M | $20M | $19M | $20M | $20M | $21M |
| Net Income Avg | $16M | $17M | $11M | $16M | $18M | $19M |
| Low | $16M | $17M | $11M | $16M | $18M | $19M |
| High | $16M | $17M | $11M | $16M | $18M | $19M |
| EPS Avg | $0.32 | $0.35 | $0.23 | $0.33 | $0.37 | $0.38 |
| Low | $0.32 | $0.35 | $0.23 | $0.33 | $0.37 | $0.38 |
| High | $0.32 | $0.35 | $0.23 | $0.33 | $0.37 | $0.38 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |